Trial intelligence / Profile preview

FICB for Pain Control After Total Hip Arthroplasty

NCT03375112Phase 4Completed

Sponsor
Henry Ford Health
Start
Jul 2017
Primary completion
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Henry Ford Health. Started Jul 2017; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03375112.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03375112.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call